论文部分内容阅读
德国拜耳（Ｂａｖｅｒ）公司２００１年８月８日宣布，在 除日本以外的全球范围内撤下各种剂量的商品 名为Ｂａｙｃｏｌ／Ｌｉｐｏｂａｙ（主药成分为西立伐他汀，ｃｅｒｉｖａｓｔａｔｉｎ）的降脂药。之后，考虑到吉非贝齐（ｇｅｍｆｉｂｒｏｚｉｌ）即将在日本上市，进而有
Germany’s Baver company announced on August 8, 2001 that it has withdrawn all kinds of lipid-lowering drugs under the trade name Baycol / Lipobay (cerivastatin) at a global scale except Japan. . Afterwards, considering that gemfibrozil is going to be listed in Japan, there will be more